Download PDF
CC BY-NC-ND 4.0 · Journal of Diabetes and Endocrine Practice 2021; 04(02): 46-58
DOI: 10.4103/jdep.jdep_7_21
Review Article

Ramadan fasting and diabetes (2020): The year in review

Khadija Hafidh
1   Department of Medicine, Dubai Medical College
2   Department of Diabetes and Endocrinology, Rashid Hospital, DHA, Dubai
,
Khawla Ali
3   Department of Medicine, Royal College of Surgeons in Ireland Medical University of Bahrain, Adliya
,
Saira Abbas
2   Department of Diabetes and Endocrinology, Rashid Hospital, DHA, Dubai
,
Salem Beshyah
1   Department of Medicine, Dubai Medical College
› Author Affiliations
› Further Information
   Permissions and Reprints

The literature on health aspects of Ramadan fasting (RF) is widely spread in many journals, making it not readily accessible to those interested in the subject. We aimed to provide a narrative overview of the global literature production in 1 year (2020) on diabetes and RF. This was a narrative, nonsystematic review of the international literature from a single major medical online database (i.e., PubMed) during the year 2020. The search term “Ramadan fasting AND Diabetes” was used, and the relevant literature was narrated in a concise thematic account. The publications spanned a vast array of topics related to RF, including assessments of safety and efficacy profiles of older and newer diabetes therapies, modes of insulin delivery, evaluating the role of utilizing advanced technology for the treatment, and monitoring of blood glucose during RF. Increased interest was evident in capturing patients' perspectives and healthcare professionals' perceptions, attitudes, and practices during Ramadan. Fasting by high-risk groups was studied. Not surprisingly, some reports covered COVID-19 and Ramadan and the role of telemedicine in ramadan. The current literature review presents this year's research data on the safety of fasting practices, care models, and patients' experiences and perspectives. It emphasizes the need for more comprehensive interventions for high-risk patients, promoting newer antidiabetic medicines, and advanced technology for safer fasting practices.

Keywords

Children and adolescents - diabetes - diabetic ketoacidosis - epidemiology - healthcare professionals - high-risk patients - hypoglycemia - literature - patients' perspectives - perceptions - Ramadan fasting - COVID-19 - ethnic - muslims

Financial support and sponsorship

Nil.




Publication History

Received: 01 May 2021

Accepted: 01 May 2021

Article published online:
06 July 2022

© 2021. Gulf Association of Endocrinology and Diabetes (GAED). All rights reserved. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Beshyah SA Fasting Ramadan for people with diabetes: Medicine and Fiqh united at last. Ibnosina J Med Biomed Sci 2009;1:1-5.
  • 2 Nouira S, Melki S, Nouira H, Ben Abdelaziz A, Azzaza M, El Mhamdi S, et al. Ramadan and Health. Bibliometric study of the biomedical literature indexed in “Medline” database. Tunis Med 2019;97:1160-8.
  • 3 Beshyah WS, Beshyah SA. Bibliometric analysis of the literature on Ramadan fasting and diabetes in the past three decades (1989-2018). Diabetes Res Clin Pract 2019;151:313-22.
  • 4 Sherif IH, Lakhdar AA. Ramadan fasting and the medical patient: Consensus is welcome but more evidence is needed. Ibnosina J Med Biomed Sci 2010;2:237-9.
  • 5 Khalil AB, Lakhdar AA, Benbarka MM, Sherif IH. Research and Ramadan fasting: Not too much of a good thing! Ibnosina J Med Biomed Sci 2018;10:35-6.
  • 6 Beshyah SA, Hajjaji IM, Ibrahim WH, Deeb A, El-Ghul EM, Akkari KB, et al. The year in Ramadan fasting research (2017): A narrative review. Ibnosina J Med Biomed Sci 2018;10:39-53.
  • 7 Beshyah SA, Badi A, El-Ghul AM, Ghabroun A, Doughman KK, Eledrisi MS. Special communication: The year in Ramadan fasting and health (2018). Ibnosina J Med Biomed Sci 2019;11:151-70.
  • 8 Beshyah SA, Ali KF, Hafidh K, Hajjaji IM. Ramadan fasting and diabetes 2019: The year in review. Diabetes Res Clin Pract 2021;172:108593.
  • 9 Al Awadi FF, Echtay A, Al Arouj M, Sabir Ali S, Shehadeh N, Al Shaikh A, et al. Patterns of diabetes care among people with type 1 diabetes during Ramadan: An international prospective study (DAR-MENA T1DM). Adv Ther 2020;37:1550-63.
  • 10 Syed F, Arif MA, Ramzan A, Niazi R, Murtaza MI, Javed A. DAR-GRACE: Diabetes and Ramadan: Glycaemic control, physician counselling and patient practices-Experience from a tertiary care hospital in Pakistan. J Pak Med Assoc 2020;70:1990-5.
  • 11 Mansouri D, Khayat E, Khayat M, Aboawja M, Aseeri A, Banah F, et al. Self-monitoring of blood glucose and hypoglycemia association during fasting in Ramadan among patients with diabetes. Diabetes Metab Syndr Obes 2020;13:1035-41.
  • 12 Kovil R, Shaikh N. Study of beneficial impact on specific biomarkers in type 2 diabetes during Ramadan fasting (unintentional intermittent fasting). J Assoc Physicians India 2020;68:26-9.
  • 13 Rashid F, Abdelgadir E, Bashier A. A systematic review on the safety of Ramadan fasting in high-risk patients with diabetes. Diabetes Res Clin Pract 2020;164:108161.
  • 14 Abdullah K, Al-Habori M, Al-Eryani E. Ramadan intermittent fasting affects adipokines and leptin/adiponectin ratio in type 2 diabetes mellitus and their first-degree relatives. Biomed Res Int 2020;2020:1281792.
  • 15 Tahapary DL, Astrella C, Kristanti M, Harbuwono DS, Soewondo P. The impact of Ramadan fasting on metabolic profile among type 2 diabetes mellitus patients: A meta-analysis. Diabetes Metab Syndr 2020;14:1559-70.
  • 16 Shaltout I, Zakaria A, Abdelwahab AM, Hamed A, Elsaid NH, Attia MA. Culturally based pre-Ramadan education increased benefits and reduced hazards of Ramadan fasting for type 2 diabetic patients. J Diabetes Metab Disord 2020;19:179-86.
  • 17 Darko N, Dallosso H, Hadjiconstantinou M, Hulley K, Khunti K, Davies M. Qualitative evaluation of A Safer Ramadan, a structured education programme that addresses the safer observance of Ramadan for Muslims with type 2 diabetes. Diabetes Res Clin Pract 2020;160:107979.
  • 18 Gad H, Al-Muhannadi H, Purra H, Mussleman P, Malik RA. The effect of Ramadan focused education on patients with type 2 diabetes: A systematic review and meta-analysis. Diabetes Res Clin Pract 2020;162:108122.
  • 19 Tourkmani AM, Abdelhay O, Alharbi TJ, Bin Rsheed AM, Azmi Hassali M, Alrasheedy AA, et al. Impact of Ramadan-focused diabetes education on hypoglycemia risk and metabolic control for patients with type 2 diabetes mellitus: A systematic review. Int J Clin Pract 2021;75:e13817. doi: 10.1111/ijcp.13817. Epub 2020 Nov 22.
  • 20 Mohd Yusof BN, Wan Zukiman WZ, Abu Zaid Z, Omar N, Mukhtar F, Yahya NF, et al. Comparison of structured nutrition therapy for Ramadan with standard care in type 2 diabetes patients. Nutrients 2020;12:813.
  • 21 Hsu YT, Chen HJ, Yufika A, Zufry H. Dietary knowledge, preferences and behaviors in Ramadan among Muslim patients with type 2 diabetes. Diabetes Res Clin Pract 2020;170:108474.
  • 22 Assaad Khalil S, Gaber Amin N, Mohamed Ibrahim A, Zakaria Zaky D, Mounir Bishay M. Glycemic indices of dates “Ramadan Symbolic Food” in patients with type 2 diabetes using continuous glucose monitoring system. Diabetes Res Clin Pract 2021;172:108563.
  • 23 Sahay R, Hafidh K, Djaballah K, Coudert M, Azar S, Shehadeh N, et al. Safety of lixisenatide plus basal insulin treatment regimen in Indian people with type 2 diabetes mellitus during Ramadan fast: A post hoc analysis of the LixiRam randomized trial. Diabetes Res Clin Pract 2020;163:108148.
  • 24 Lum ZK, Khoo ZR, Toh WY, Kamaldeen SA, Shakoor A, Tsou KY, et al. Efficacy and safety of use of the fasting algorithm for Singaporeans with type 2 diabetes (FAST) during Ramadan: A prospective, multicenter, randomized controlled trial. Ann Fam Med 2020;18:139-47.
  • 25 Kalra S, Sahay R, Tiwaskar M, Priya G, Das S, Bantwal G. A prospective validation survey to assess usage of premix insulins in management of diabetes with respect to the recommendations enlisted in Indian guidelines. J Assoc Physicians India 2020;68:20-5.
  • 26 Hassanein M, Akif Buyukbese M, Malek R, Pilorget V, Naqvi M, Berthou B, et al. Real-world safety and effectiveness of insulin glargine 300 U/mL in participants with type 2 diabetes who fast during Ramadan: The observational ORION study. Diabetes Res Clin Pract 2020;166:108189.
  • 27 Hassanein M, Al Sifri S, Shaikh S, Abbas Raza S, Akram J, Pranoto A, et al. A real-world study in patients with type 2 diabetes mellitus treated with gliclazide modified-release during fasting: DIA-RAMADAN. Diabetes Res Clin Pract 2020;163:108154.
  • 28 Gad H, Hayat T, Al-Muhannadi H, Malik BR, Mussleman P, Malik RA. Efficacy and safety of the newer oral hypoglycemic agents in patients with T2DM during Ramadan: A systematic review and meta-analysis. Diabetes Res Clin Pract 2021;172:108562.
  • 29 Beshyah SA, Hafidh K, Shaikh TG. Evolving physicians' perceptions and practices regarding use of SGLT2 inhibitors for type 2 diabetes during Ramadan fasting. Diabetes Res Clin Pract 2020;168:108389.
  • 30 Harbuwono DS, Kurniawan F, Sudarsono NC, Tahapary DL. The impact of Ramadan fasting on glucose variability in type 2 diabetes mellitus patients on oral anti diabetic agents. PLoS One 2020;15:e0234443.
  • 31 Ahmedani MY, Ghafoor E. Achieving safer Ramadan fasting by keeping flexible glycemic targets during the day and tighter targets during the night in insulin treated people with type 2 diabetes. Diabetes Res Clin Pract 2020;165:108234.
  • 32 Saadane I, Ali T, El-Laboudi A, Lessan N. Ramadan fasting in insulin-treated patients is associated with potentially unfavourable changes in glucose metrics: A flash glucose monitoring (FGM) study. Diabetes Res Clin Pract 2021;172:108592.
  • 33 Elhadd T, Bashir M, Baager KA, Ali HA, Almohannadi DH, Dabbous Z, et al. Mitigation of hypoglycemia during Ramadan using the flash glucose monitoring system following dose adjustment of insulin and sulphonylurea in patients taking multiple glucose-lowering therapies (The PROFAST-IT Study). Diabetes Res Clin Pract 2021;172:108589.
  • 34 Elhadd T, Mall R, Bashir M, Palotti J, Fernandez-Luque L, Farooq F, et al. Artificial intelligence (AI) based machine learning models predict glucose variability and hypoglycaemia risk in patients with type 2 diabetes on a multiple drug regimen who fast during Ramadan (The PROFAST-IT Ramadan study). Diabetes Res Clin Pract 2020;169:108388.
  • 35 Ahmed SH, Gallo S. Looping with do-it-yourself artificial pancreas systems during Ramadan fasting in type 1 diabetes mellitus: Perspectives of a user and a physician. Diabetes Ther 2020;11:2453-63.
  • 36 Alawadi F, Alsaeed M, Bachet F, Bashier A, Abdulla K, Abuelkheir S, et al. Impact of provision of optimum diabetes care on the safety of fasting in Ramadan in adult and adolescent patients with type 1 diabetes mellitus. Diabetes Res Clin Pract 2020;169:108466.
  • 37 Elamari S, Elaziz S, Chadli A, Farouqi A. Management of diabetes during Ramadan fasting: Applications of international recommendations in clinical practice. Pan Afr Med J 2020;36:316.
  • 38 Catic T, Jusufovic R. Physician practice and knowledge on diabetes management during Ramadan in Bosnia and Herzegovina. Mater Sociomed 2020;32:57-61.
  • 39 Ulhaque MS, Bin Zafar A, Ahmed F, Ahmedani MY. Role of 24-hour helpline service in the management of diabetes during the holy month of Ramadan. Cureus 2020;12:e7320.
  • 40 Hussain S, Choudhary P, Hopkins D. Type 1 diabetes and fasting in Ramadan: Time to rethink classification of risk? Lancet Diabetes Endocrinol 2020;8:656-8.
  • 41 Koudstaal K, Verdonk P, Bartels E. “At this age, a Moroccan woman's life's work is over”-older Moroccan-Dutch migrant women's perceptions of health and lifestyle, with a focus on Ramadan experiences: Qualitative research integrating education and consultation. Int J Equity Health 2020;19:34.
  • 42 Alsunni AA, Albaker WI, Almansour AH, Alenazi AS, Alaftan MS, Badar A. Knowledge, attitude and practice regarding Ramadan fasting and related determinants in patients with type 2 diabetes at a Saudi diabetes clinic. Diabetes Metab Syndr Obes 2020;13:151-9.
  • 43 Liao J, Wang T, Li Z, Xie H, Wang S. Experiences and views of people with diabetes during Ramadan fasting: A qualitative meta-synthesis. PLoS One 2020;15:e0242111.
  • 44 Alfahadi A, Habib SS, Alharbi K, Alturki D, Alshamrani F, Bashir S. Assessment of fatigue severity and neurocognitive functions in the real setting of Ramadan in patients with type 2 diabetes mellitus. Heliyon 2020;6:e03997.
  • 45 Alghamdi AS, Alghamdi KA, Jenkins RO, Alghamdi MN, Haris PI. Impact of Ramadan on physical activity and sleeping patterns in individuals with type 2 diabetes: The first study using Fitbit device. Diabetes Ther 2020;11:1331-46.
  • 46 Yousuf S, Syed A, Ahmedani MY. To explore the association of Ramadan fasting with symptoms of depression, anxiety, and stress in people with diabetes. Diabetes Res Clin Pract 2021;172:108545.
  • 47 Chowdhury TA, Waqar S, Hussain S, Ahmed SH, Syed A, Karamat A, et al. COVID-19, diabetes and Ramadan. Diabetes Ther 2020;11:2447-51.
  • 48 Tootee A, Esfahani EN, Larijani B. Diabetes management during Ramadan amid COVID-19 pandemic. Daru 2020;28:795-8.
  • 49 Tootee A, Larijani B. Ramadan fasting during COVID-19 pandemic. J Diabetes Metab Disord 2020;19:1-4.
  • 50 Hanif W, Patel V, Ali SN, Karamat A, Saeed M, Hassanein M, et al. The South Asian Health Foundation (UK) guidelines for managing diabetes during Ramadan. Diabetes Res Clin Pract 2020;164:108145.
  • 51 Hanif S, Ali SN, Hassanein M, Khunti K, Hanif W. Managing people with diabetes fasting for Ramadan during the COVID-19 pandemic: A South Asian Health Foundation Update. Diabet Med 2020;37:1094-102.
  • 52 Hassanein M, Alamoudi RM, Kallash MA, Aljohani NJ, Alfadhli EM, Tony LE, et al. Ramadan fasting in people with type 1 diabetes during COVID-19 pandemic: The DaR Global survey. Diabetes Res Clin Pract 2021;172:108626.
  • 53 Khan H, Chowdhury A, Lasker SS, Chowdhury TA. The effect of COVID-19 on Ramadan fasting in people with diabetes in East London 2020: The East London diabetes in Ramadan survey. Diabetes Res Clin Pract 2020;169:108476.
  • 54 Al-Sofiani ME, Alyusuf EY, Alharthi S, Alguwaihes AM, Al-Khalifah R, Alfadda A. Rapid implementation of a diabetes telemedicine clinic during the coronavirus disease 2019 outbreak: Our protocol, experience, and satisfaction reports in Saudi Arabia. J Diabetes Sci Technol 2021;15:329-38.
  • 55 Zabeen B, Ahmed B, Nahar J. Young people with type 1 diabetes on insulin pump therapy could fast safely during COVID-19 pandemic Ramadan: A telemonitoring experience in Bangladesh. J Diabetes Investig 2020 Oct 24. doi: 10.1111/jdi.13449. Epub ahead of print.